Medical NewsLupin gets 6 USFDA observations for Nagpur facility DRRA4 months ago01 mins [ad_1] Lupin gets 6 USFDA observations for Nagpur facility We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link Post navigation Previous: FDA’s Crackdown on Rx Drug Promotion Ramps Up with Release of LettersNext: Pune Students Help Farmers Test Soil & Boost Crop Health Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
FDA again rejects tabelecleucel for EBV-driven post-transplant lymphoproliferative disease DRRA1 day ago 0